Studies found that downregulation of c-Myc inhibits the growth and migration of cisplatin-resistant bladder cancer cells [12] and increases the susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in human melanoma cells [13]. The gene discussed is MYC; the disease is urinary bladder cancer.